Adelya Yachnin

Affiliations

Kaplan Medical Center, Rehovot, Israel.

Réseau de co-auteurs

Rebecca C Arend 1 collaboration

Bradley J Monk 1 collaboration

Ronnie Shapira-Frommer 1 collaboration

Ashley F Haggerty 1 collaboration

Edwin A Alvarez 1 collaboration

Amnon Amit 1 collaboration

Angeles Alvarez Secord 1 collaboration

Carolyn Muller 1 collaboration

Antonio Casado Herraez 1 collaboration

Thomas J Herzog 1 collaboration

Krishnansu S Tewari 1 collaboration

Joshua G Cohen 1 collaboration

Marilyn Huang 1 collaboration

Laura L Holeman 1 collaboration

Jonathan A Ledermann 1 collaboration

Tamar Rachmilewitz Minei 1 collaboration

Marc Buyse 1 collaboration

Shifra Fain Shmueli 1 collaboration

Michal Lavi 1 collaboration

Dror Harats 1 collaboration

Richard T Penson 1 collaboration

None None 1 collaboration

G E Konecny 1 collaboration

A E Wahner Hendrickson 1 collaboration

T M Davidson 1 collaboration

B J Winterhoff 1 collaboration

S Ma 1 collaboration

S Mahner 1 collaboration

J Sehouli 1 collaboration

P A Fasching 1 collaboration

G Feisel-Schwickardi 1 collaboration

M Poelcher 1 collaboration

L D Roman 1 collaboration

A Rody 1 collaboration

B Y Karlan 1 collaboration

S A Mullany 1 collaboration

H Chen 1 collaboration

I L Ray-Coquard 1 collaboration

D M Provencher 1 collaboration

A Yachnin 1 collaboration

P H Cottu 1 collaboration

J A Glaspy 1 collaboration

P Haluska 1 collaboration

D J Slamon 1 collaboration

Adelya Yachnin

Affiliations

Publications (2)

Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018).

Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer.

Réseau de co-auteurs